Policy Solutions

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.

Connect with PhRMA

For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA

The Bayh-Dole Act (commonly referred to simply as “Bayh-Dole” and codified at 35 U.S.C. §§ 200-211) created the uniform framework that facilitates orderly and efficient technology transfer from universities and other institutions receiving government research funding to the private sector. Bayh-Dole allows universities and other institutions to own title to the patents arising directly from their research activities. This paper focuses specifically on the contributions of Bayh-Dole in fostering technology transfer in the life sciences and current threats to this robust framework.

Policy Solutions image

download

Report

Science